Priya Sharma
Analyst

Priya Sharma

Equity & ETF Correspondent

Priya covers US and international equities, ETFs, and index funds. Her analysis focuses on long-term portfolio construction and dividend investing strategies.

Priya Sharma's Articles (971)
Super Micro Plunges 11% on $7B Equity Raise to Fund AI Server Expansion
Stocks
Super Micro Plunges 11% on $7B Equity Raise to Fund AI Server Expansion
Oracle Stock Falls 3% as Earnings Test AI Investment Thesis Amid Rising Debt
Stocks
Oracle Stock Falls 3% as Earnings Test AI Investment Thesis Amid Rising Debt
Asian Tech Stocks Tumble as AI Rally Falters on Valuation Fears, SoftBank Plunges 10%
Stocks
Asian Tech Stocks Tumble as AI Rally Falters on Valuation Fears, SoftBank Plunges 10%
BYD Chairman Sets Five-Year Goal to Become World's Top Automaker Amid Export Surge
Stocks
BYD Chairman Sets Five-Year Goal to Become World's Top Automaker Amid Export Surge
DraftKings Stock Surges 11% as Prediction Market Volume Hits $3.1 Billion
Stocks
DraftKings Stock Surges 11% as Prediction Market Volume Hits $3.1 Billion
Broadcom Drops 6% as AI Revenue Forecast Fails to Impress, Despite $35B Data Center Deal
Stocks
Broadcom Drops 6% as AI Revenue Forecast Fails to Impress, Despite $35B Data Center Deal
Veeco Surges 19% on NSA500 Follow-On Order as Chip Demand Accelerates
Stocks
Veeco Surges 19% on NSA500 Follow-On Order as Chip Demand Accelerates
Tesla Stock Tumbles 5% as Tech Selloff, SpaceX IPO Jitters Weigh
Stocks
Tesla Stock Tumbles 5% as Tech Selloff, SpaceX IPO Jitters Weigh
Nvidia Stock Slips 1.3% as Broad Market Weakness Overshadows Apple AI Deal
Stocks
Nvidia Stock Slips 1.3% as Broad Market Weakness Overshadows Apple AI Deal
Intuit Stock Plunges 62% in 2025, Becomes Nasdaq 100's Worst Performer: A Contrarian Play?
Stocks
Intuit Stock Plunges 62% in 2025, Becomes Nasdaq 100's Worst Performer: A Contrarian Play?
AstraZeneca Obesity Pill Shows 11.8% Weight Loss; Analysts See Upside Beyond Consensus
Stocks
AstraZeneca Obesity Pill Shows 11.8% Weight Loss; Analysts See Upside Beyond Consensus
SpaceX IPO Oversubscribed 2x Ahead of June 11 Pricing: Valuation Debate Intensifies
Stocks
SpaceX IPO Oversubscribed 2x Ahead of June 11 Pricing: Valuation Debate Intensifies